Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets

YJ Lim, NA Sidor, NC Tonial, A Che, BL Urquhart - Toxins, 2021 - mdpi.com
Chronic kidney disease (CKD) is a progressive loss of renal function. The gradual decline in
kidney function leads to an accumulation of toxins normally cleared by the kidneys, resulting …

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal …

C Zoccali, F Mallamaci, M Adamczak… - Cardiovascular …, 2023 - academic.oup.com
Chronic kidney disease (CKD) is classified into five stages with kidney failure being the most
severe stage (stage G5). CKD conveys a high risk for coronary artery disease, heart failure …

The critical role of Faecalibacterium prausnitzii in human health: An overview

HE Leylabadlo, R Ghotaslou, MM Feizabadi… - Microbial …, 2020 - Elsevier
Faecalibacterium prausnitzii (F. prausnitzii) is one of the most abundant bacterial species in
the colon of healthy human adults and representing more than 5% of the total bacterial …

FGF23 and klotho at the intersection of kidney and cardiovascular disease

D Edmonston, A Grabner, M Wolf - Nature Reviews Cardiology, 2024 - nature.com
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease
(CKD). As CKD progresses, CKD-specific risk factors, such as disordered mineral …

Management of osteoporosis in patients with chronic kidney disease

M Abdalbary, M Sobh, S Elnagar, MA Elhadedy… - Osteoporosis …, 2022 - Springer
Patients with CKD have a 4–fivefold higher rate of fractures. The incidence of fractures
increases with deterioration of kidney function. The process of skeletal changes in CKD …

New developments in the biology of fibroblast growth factors

DM Ornitz, N Itoh - WIREs mechanisms of disease, 2022 - Wiley Online Library
The fibroblast growth factor (FGF) family is composed of 18 secreted signaling proteins
consisting of canonical FGFs and endocrine FGFs that activate four receptor tyrosine …

Newer formulations of intravenous iron: a review of their chemistry and key safety aspects–hypersensitivity, hypophosphatemia, and cardiovascular safety

I Blumenstein, S Shanbhag, P Langguth… - Expert opinion on …, 2021 - Taylor & Francis
Introduction: The newest intravenous (IV) iron products show an improved safety profile over
predecessors, allowing for the rapid administration of relatively high doses. Ferric …

The basics of phosphate metabolism

CA Wagner - Nephrology Dialysis Transplantation, 2024 - academic.oup.com
Phosphorus is an essential mineral that is, in the form of inorganic phosphate (Pi), required
for building cell membranes, DNA and RNA molecules, energy metabolism, signal …

New aspects of the kidney in the regulation of fibroblast growth factor 23 (FGF23) and mineral homeostasis

ML Mace, K Olgaard, E Lewin - International journal of molecular sciences, 2020 - mdpi.com
The bone-derived hormone fibroblast growth factor 23 (FGF23) acts in concert with
parathyroid hormone (PTH) and the active vitamin D metabolite calcitriol in the regulation of …

The importance of phosphate control in chronic kidney disease

K Tsuchiya, T Akihisa - Nutrients, 2021 - mdpi.com
A series of problems including osteopathy, abnormal serum data, and vascular calcification
associated with chronic kidney disease (CKD) are now collectively called CKD-mineral bone …